Cunjing Yu

Prostaglandin E ₂ constrains systemic inflammation through an innate lymphoid cell–IL-22 axis

Rodger Duffin, Richard A. O’Connor, Siobhan Crittenden et al. · Science · 2016 · 186 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial

Caicun Zhou, Dingzhi Huang, Yun Fan et al. · Journal of Thoracic Oncology · 2022 · 104 citations · Full text

Medicine, Oncology, Pharmacology +17

Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis

Calum T. Robb, Henry J. McSorley, Jinju Lee et al. · Journal of Allergy and Clinical Immunology · 2017 · 71 citations · Full text

Life Sciences, Dermatology, Immunology +16

Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells

E. Natafji, Cunjing Yu, Sharizan Abdul-Ghaffar et al. · Journal of Allergy and Clinical Immunology · 2016 · 42 citations · Full text

Medicine, Dermatology, Immunology +17

Use of BIBW 2992, a novel irreversible EGFR/HER2 TKI, to induce regression in patients with adenocarcinoma of the lung and activating EGFR mutations: Preliminary results of a single-arm phase II clinical trial

Chenglin Yang, Jen-Fu Shih, Tzu‐Chieh Chao et al. · Journal of Clinical Oncology · 2008 · 32 citations

Medicine, Pharmacology, Pharmacotherapy +17